240 related articles for article (PubMed ID: 26203705)
21. The role of routine imaging procedures in the detection of relapse of patients with Hodgkin lymphoma and aggressive non-Hodgkin lymphoma.
Goldschmidt N; Or O; Klein M; Savitsky B; Paltiel O
Ann Hematol; 2011 Feb; 90(2):165-71. PubMed ID: 20706721
[TBL] [Abstract][Full Text] [Related]
22. FDG-PET in the clinical management of Hodgkin lymphoma.
Hutchings M; Eigtved AI; Specht L
Crit Rev Oncol Hematol; 2004 Oct; 52(1):19-32. PubMed ID: 15363464
[TBL] [Abstract][Full Text] [Related]
23. [Therapy in Hodgkin disease and non-Hodgkin lymphomas].
Sréter L
Orv Hetil; 2009 Apr; 150(14):651-5. PubMed ID: 19318337
[TBL] [Abstract][Full Text] [Related]
24. Discrepancies and priorities in staging and restaging malignant lymphoma by SPET, SPET/CT, PET/CT and PET/MRI.
Chavdarova LI; Tzonevska AD; Piperkova EN
Hell J Nucl Med; 2013; 16(3):223-9. PubMed ID: 24137584
[TBL] [Abstract][Full Text] [Related]
25. Revised International Pediatric Non-Hodgkin Lymphoma Staging System.
Rosolen A; Perkins SL; Pinkerton CR; Guillerman RP; Sandlund JT; Patte C; Reiter A; Cairo MS
J Clin Oncol; 2015 Jun; 33(18):2112-8. PubMed ID: 25940716
[TBL] [Abstract][Full Text] [Related]
26. Unusual discrepancy between CT and PET/CT in the initial staging of Hodgkin's lymphoma.
Michelis FV; Exarhos DN; Tzannou IA; Karmiris T; Nikiforakis E
Acta Oncol; 2011 Apr; 50(3):474-6. PubMed ID: 20715895
[No Abstract] [Full Text] [Related]
27. Pediatric and adolescent lymphoma: comparison of whole-body STIR half-Fourier RARE MR imaging with an enhanced PET/CT reference for initial staging.
Punwani S; Taylor SA; Bainbridge A; Prakash V; Bandula S; De Vita E; Olsen OE; Hain SF; Stevens N; Daw S; Shankar A; Bomanji JB; Humphries PD
Radiology; 2010 Apr; 255(1):182-90. PubMed ID: 20308456
[TBL] [Abstract][Full Text] [Related]
28. Revised response criteria for malignant lymphoma.
Cheson BD; Pfistner B; Juweid ME; Gascoyne RD; Specht L; Horning SJ; Coiffier B; Fisher RI; Hagenbeek A; Zucca E; Rosen ST; Stroobants S; Lister TA; Hoppe RT; Dreyling M; Tobinai K; Vose JM; Connors JM; Federico M; Diehl V;
J Clin Oncol; 2007 Feb; 25(5):579-86. PubMed ID: 17242396
[TBL] [Abstract][Full Text] [Related]
29. Assessment of response to therapy using conventional imaging.
Rankin SC
Eur J Nucl Med Mol Imaging; 2003 Jun; 30 Suppl 1():S56-64. PubMed ID: 12664137
[TBL] [Abstract][Full Text] [Related]
30. [Non-Hodgkin's lymphoma staging with PET-CT scan].
Setoain X; López-Guillermo A
Med Clin (Barc); 2011 Oct; 137(9):402-4. PubMed ID: 21696781
[No Abstract] [Full Text] [Related]
31. Staging of lymphoma in adults.
Sandrasegaran K; Robinson PJ; Selby P
Clin Radiol; 1994 Mar; 49(3):149-61. PubMed ID: 8143402
[No Abstract] [Full Text] [Related]
32. Positron emission tomography in the management of Hodgkin lymphoma.
Connors JM
Hematology Am Soc Hematol Educ Program; 2011; 2011():317-22. PubMed ID: 22160052
[TBL] [Abstract][Full Text] [Related]
33. Application of the Lugano Classification for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The PRoLoG Consensus Initiative (Part 2-Technical).
Ricard F; Barrington S; Korn R; Brueggenwerth G; Trotman J; Cheson B; Salles G; Schwartz L; Goldmacher G; Jarecha R; Narang J; Broussais F; Galette P; Liu M; Bajpai S; Perlman E; Gillis J; Smalberg I; Terve P; Zahlmann G; Schmid A
J Nucl Med; 2023 Feb; 64(2):239-243. PubMed ID: 35835581
[TBL] [Abstract][Full Text] [Related]
34. [Clinical staging and diagnosis of malignant lymphoma].
Niibe H; Tamaki Y; Akimoto T
Gan No Rinsho; 1988 Apr; 34(5):541-54. PubMed ID: 3164415
[TBL] [Abstract][Full Text] [Related]
35. Application of the Lugano Classification for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The PRoLoG Consensus Initiative (Part 1-Clinical).
Ricard F; Cheson B; Barrington S; Trotman J; Schmid A; Brueggenwerth G; Salles G; Schwartz L; Goldmacher G; Jarecha R; Narang J; Broussais F; Galette P; Liu M; Bajpai S; Perlman E; Gillis J; Smalberg I; Terve P; Zahlmann G; Korn R
J Nucl Med; 2023 Jan; 64(1):102-108. PubMed ID: 35835580
[TBL] [Abstract][Full Text] [Related]
36. Clinical presentation and staging of Hodgkin lymphoma.
Gallamini A; Hutchings M; Ramadan S
Semin Hematol; 2016 Jul; 53(3):148-54. PubMed ID: 27496305
[TBL] [Abstract][Full Text] [Related]
37. The value of positron emission tomography in prognosis and response assessment in non-Hodgkin lymphoma.
Dunleavy K; Mikhaeel G; Sehn LH; Hicks RJ; Wilson WH
Leuk Lymphoma; 2010 Aug; 51 Suppl 1():28-33. PubMed ID: 20658958
[TBL] [Abstract][Full Text] [Related]
38. [Bone lymphoma].
Merino Menéndez S; Vega González ML; Blanco Cabellos JA
Sangre (Barc); 1998 Dec; 43(6):521-5. PubMed ID: 10089813
[No Abstract] [Full Text] [Related]
39. PET/CT for Staging; Past, Present, and Future.
El-Galaly TC; Gormsen LC; Hutchings M
Semin Nucl Med; 2018 Jan; 48(1):4-16. PubMed ID: 29195617
[TBL] [Abstract][Full Text] [Related]
40. PET-guided treatment for personalised therapy of Hodgkin lymphoma and aggressive non-Hodgkin lymphoma.
Phillips EH; Iype R; Wirth A
Br J Radiol; 2021 Nov; 94(1127):20210576. PubMed ID: 34520242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
